Marc Hertz

Co-founder & CEO at GRI Bio, Inc. - San Diego, California, United States

Marc Hertz's Colleagues at GRI Bio, Inc.
Marc Hertz's Contact Details
HQ
(619) 400-1171
Location
California,United States
Company
GRI Bio, Inc.
Marc Hertz's Company Details
GRI Bio, Inc. logo, GRI Bio, Inc. contact details

GRI Bio, Inc.

San Diego, California, United States • 5 Employees
Research

GRI is a development stage biotech company fundamentally changing the way inflammatory disease is treated. GRI's Natural Killer T (NKT) cell-based therapies are being developed for liver disease and acute liver failure. NKT cells share properties of both NK and T cells and are a functional link between the innate and adaptive immune responses. Type 1 NKT cells play a critical role in initiating and propagating the inflammatory response and the hepatic injury that is observed in liver disease. GRI's lead program, GRI-0621, is an inhibitor of type I NKT cells and is being developed as a novel oral therapeutic for acute liver failure.

Details about GRI Bio, Inc.
Frequently Asked Questions about Marc Hertz
Marc Hertz currently works for GRI Bio, Inc..
Marc Hertz's role at GRI Bio, Inc. is Co-founder & CEO.
Marc Hertz's email address is ***@gribio.com. To view Marc Hertz's full email address, please signup to ConnectPlex.
Marc Hertz works in the Research industry.
Marc Hertz's colleagues at GRI Bio, Inc. are Gulcan Aydin and others.
Marc Hertz's phone number is (619) 400-1171
See more information about Marc Hertz